Nuvigil

Nuvigil is a brand name of armodafinil, approved by the FDA in the following formulation(s):

NUVIGIL (armodafinil - tablet; oral)

• 
  Manufacturer: CEPHALON
  
  Approval date: June 15, 2007
  
  Strength(s): 150MG, 250MG ^[RLD], 50MG
  

Has a generic version of Nuvigil been approved?

No. There is currently no therapeutically equivalent version of Nuvigil available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nuvigil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
  Patent 7,132,570
  Issued: November 7, 2006
  Inventor(s): Neckebrock; Olivier & Leproust; Pierre
  Assignee(s): Cephalon France
  The invention relates to a process for the preparation of crystalline forms of the optical enantiomers of modafinil, comprising stages comprising: i) dissolving one of the optical enantiomers of modafinil in a solvent other than ethanol, ii) crystallising the modafinil enantiomer, iii) recovering the crystalline form of the modafinil enantiomer so obtained. The invention also relates to a process for the preparation of the optical enantiomers of modafinil.
  
  Patent expiration dates:
  
  
  • December 18, 2023
    
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • June 18, 2024
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Pharmaceutical formulations of modafinil
  Patent 7,297,346
  Issued: November 20, 2007
  Inventor(s): Corvari; Vincent & Grandolfi; George & Parikh; Alpa
  Assignee(s): Cephalon Inc.
  The present invention is related to compositions of modafinil, including compositions of modafinil and one or more diluents, disintegrants, binders and lubricants, and the processes for their preparation thereof.
  
  Patent expiration dates:
  
  
  • November 29, 2023
    
    ✓ 
    Drug product
  
  
  
  • May 29, 2024
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Acetamide derivative having defined particle size
  Patent RE37516
  Issued: January 15, 2002
  Inventor(s): Peter E.; Grebow & Vincent; Corvari & David; Stong
  Assignee(s): Cephalon, Inc.
  Pharmaceutical compositions comprising modafinil in the form of particles of defined size. The particle size of modafinil can have a significant effect on the potency and safety profile of the drug.
  
  Patent expiration dates:
  
  
  • October 6, 2014
    
    ✓ 
    Patent use: IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE SLEEPINESS ASSOCIATED WITH NARCOLEPSY, OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME, AND SHIFT WORK SLEEP DISORDER
    ✓ 
    Drug product
  
  
  
  • April 6, 2015
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Nuvigil Consumer Information (Drugs.com)
• Nuvigil Consumer Information (Wolters Kluwer)
• Nuvigil Consumer Information (Cerner Multum)
• Nuvigil Advanced Consumer Information (Micromedex)
• Nuvigil AHFS DI Monographs (ASHP)
• Armodafinil Consumer Information (Wolters Kluwer)
• Armodafanil Consumer Information (Cerner Multum)
• Armodafinil Consumer Information (Cerner Multum)
• Armodafinil Advanced Consumer Information (Micromedex)
• Armodafinil AHFS DI Monographs (ASHP)